GSK Investigational Site
Mülheim, North Rhine-Westphalia 45475
0 studies enrolling now · 4 studies all time
What they study most
Lung Cancer, Non-Small Cell, Neoplasms, Breast, Neoplasms, Prostate, Urinary Tract Infections
Studies at this site
- A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) — Completed
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
- Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed